N~2~-methyl-N~2~-(2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine-7-sulfonyl)-N-{4-[(piperidin-1-yl)methyl]phenyl}glycinamide
Chemical Structure Depiction of
N~2~-methyl-N~2~-(2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine-7-sulfonyl)-N-{4-[(piperidin-1-yl)methyl]phenyl}glycinamide
N~2~-methyl-N~2~-(2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine-7-sulfonyl)-N-{4-[(piperidin-1-yl)methyl]phenyl}glycinamide
Compound characteristics
| Compound ID: | E977-0413 |
| Compound Name: | N~2~-methyl-N~2~-(2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine-7-sulfonyl)-N-{4-[(piperidin-1-yl)methyl]phenyl}glycinamide |
| Molecular Weight: | 484.62 |
| Molecular Formula: | C25 H32 N4 O4 S |
| Smiles: | CN(CC(Nc1ccc(CN2CCCCC2)cc1)=O)S(c1ccc2c(CCCC(N2)=O)c1)(=O)=O |
| Stereo: | ACHIRAL |
| logP: | 2.4706 |
| logD: | 0.8887 |
| logSw: | -2.9448 |
| Hydrogen bond acceptors count: | 10 |
| Hydrogen bond donors count: | 2 |
| Polar surface area: | 84.836 |
| InChI Key: | YYZAMRHWTCZQGI-UHFFFAOYSA-N |